Browse Studies — Arctuva

Study of Biomarkers in Solid Organ and Bone Marrow Transplant Recipients to Better Treat Rejection

The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs t…

Solid Organ TransplantationBone Marrow Transplantation

Estimated

~$10 – $750

University of PittsburghNCT01163578

Phase 2

Phase 2 Study of Ruxolitinib-Based Primary Treatment for Acute GVHD

This clinical trial will study ruxolitinib-based treatment of acute graft-versus-host-disease (GVHD) that developed following allogeneic hematopoietic cell tra…

Acute Graft-versus-host DiseaseAllogeneic Bone Marrow TransplantationAdverse Effects

Estimated

~$10 – $7,500

John LevineNCT06936566

Phase 2

CD19-Directed Chimeric Antigen Receptor CD19 Redirected Autologous T Cells (CART19) for Orphan Indications of Pediatric B Cell Acute Lymphoblastic Leukemia (B ALL)

This is an open-label, four-cohort, phase 2 study to determine the efficacy of CART19 in pediatric and young adult patientswith hypodiploid (Cohort A) or t(17;…

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALLInfants With Very High Risk KMT2A B-ALLPatients With Central Nervous System Relapse Who Did Not Receive Cranial Radiation or Bone Marrow Transplantation

Estimated

~$10 – $7,500

Stephan Grupp MD PhDNCT04276870